BioCentury
ARTICLE | Company News

Arena, Suzhou Connect Biopharmaceuticals deal

July 30, 2012 7:00 AM UTC

Chinese company Suzhou Connect said it received an exclusive, worldwide license from Arena to develop and commercialize preclinical small molecule compounds to treat allergic rhinitis and atopic derma...